Glimepiride & Metformin Hydrochloride (Sustained Release) Tablets

Glimepiride & Metformin Hydrochloride (Sustained Release) Tablets

Glymtop – M1

Glimepiride & Metformin Hydrochloride (Sustained Release) Tablets combine two widely trusted antidiabetic medicines Glimepiride 1 mg and Metformin Hydrochloride 500 mg (SR) — formulated for effective control of Type 2 Diabetes Mellitus. This synergistic combination helps lower blood glucose levels by increasing insulin secretion and reducing hepatic glucose production. Manufactured by Globus Labs, the sustained-release formulation ensures steady glycemic management throughout the day.

Key Ingredients

Glimepiride (1 mg):
A sulfonylurea-class antidiabetic agent that stimulates pancreatic β-cells to release insulin, helping reduce elevated blood sugar levels effectively.

Metformin Hydrochloride (500 mg, SR):
A biguanide that lowers hepatic glucose production, slows sugar absorption from the intestine, and enhances insulin sensitivity. The sustained-release technology provides longer-lasting glycemic control with improved gastrointestinal comfort.

Benefits

  • Dual Mechanism of Action: Enhances insulin release while reducing liver glucose output for improved blood sugar control.
  • Steady Glycemic Management: SR Metformin ensures prolonged blood sugar regulation throughout the day.
  • Improves Insulin Sensitivity: Helps the body utilize insulin more effectively.
  • Reduces Risk of Diabetes Complications: Supports better long-term control, lowering the chance of nerve, kidney, and retinal damage.
  • Once-Daily Convenience: Ensures easy compliance and simplifies diabetes management.

Usage Instructions

Take Glimepiride & Metformin Hydrochloride SR Tablets once daily with food or as prescribed by your healthcare professional. Swallow the tablet whole with water. Do not crush or chew. Maintain a healthy diet and regular physical activity for optimal blood sugar regulation.

Side Effects

Mild effects may include stomach discomfort, nausea, headache, dizziness, or low blood sugar (hypoglycemia). These effects are usually temporary. Seek medical advice if symptoms persist or worsen.

General Information

  • Formulation: Glimepiride 1 mg + Metformin Hydrochloride 500 mg (Sustained Release)
  • Brand Name: Glymtop-M1
  • Manufacturer: Globus Labs
  • Medicine Type: Allopathic
  • Dosage Form: Tablet
  • Packaging Size: 10×10 Tablets
  • Packaging Type: Box
  • Product Range: Cardio-Diabetic
  • Category: Antidiabetic Medicine
  • Country of Origin: Made in India

Globus Labs brings you WHO-GMP–certified, high-quality Glimepiride 1 mg + Metformin Hydrochloride 500 mg sourced from reputed pharmaceutical manufacturers. Glymtop-M1 is formulated to deliver safe, potent, and clinically trusted support.

Grow With Us

Partner With Confidence

Whether you’re seeking a franchise opportunity, exploring wholesale distribution, or evaluating Globus Labs for international trade, we’re here to help you build a strong, profitable partnership. Let’s discuss how we can grow together and create meaningful value for your business.